A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer
Clinical trial NCT07279597 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07279597
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-10
- Primary completion
- 2027-12-10
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.